E-LIB Suche - Ergebnisse für: Kranz, H.

1

In-situ forming PLGA implants: How additives affect swellin..:

Bode, C. ; Kranz, H. ; Kruszka, A...
Journal of Drug Delivery Science and Technology. 53 (2019) - p. 101180 , 2019

Link: https://doi.org/10.1016/..

2

Often neglected: PLGA/PLA swelling orchestrates drug releas..:

Bode, C. ; Kranz, H. ; Fivez, A...
Journal of Controlled Release. 306 (2019) - p. 97-107 , 2019

Link: https://doi.org/10.1016/..

3

Coloring of PLGA implants to better understand the underlyi..:

Bode, C. ; Kranz, H. ; Siepmann, F..
International Journal of Pharmaceutics. 569 (2019) - p. 118563 , 2019

Link: https://doi.org/10.1016/..

4

In-situ forming PLGA implants for intraocular dexamethasone..:

Bode, C. ; Kranz, H. ; Siepmann, F..
International Journal of Pharmaceutics. 548 (2018) 1 - p. 337-348 , 2018

Link: https://doi.org/10.1016/..

5

Patientensicherheit oder Kosteneffizienz? Ein CIRS-Fall zwi..:

Schnoor, J. ; Kranz, H. ; Engel, A....
Gesundheitsökonomie & Qualitätsmanagement. 19 (2014) 6 - p. 281-285 , 2014

Link: https://doi.org/10.1055/..

6

Evaluation of the drug release patterns and long term stabi..:

Kranz, H. ; Gutsche, S.
International Journal of Pharmaceutics. 380 (2009) 1-2 - p. 112-119 , 2009

Link: https://doi.org/10.1016/..

7

Drug release from MCC- and carrageenan-based pellets: Exper..:

Kranz, H. ; Jürgens, K. ; Pinier, M..
European Journal of Pharmaceutics and Biopharmaceutics. 73 (2009) 2 - p. 302-309 , 2009

Link: https://doi.org/10.1016/..

8

Structure formation and characterization of injectable drug..:

Kranz, H. ; Bodmeier, R.
European Journal of Pharmaceutical Sciences. 34 (2008) 2-3 - p. 164-172 , 2008

Link: https://doi.org/10.1016/..

9

Development of a novel osmotically driven drug delivery sys..:

Guthmann, C. ; Lipp, R. ; Wagner, T..
European Journal of Pharmaceutics and Biopharmaceutics. 69 (2008) 2 - p. 667-674 , 2008

Link: https://doi.org/10.1016/..

10

A novel in situ forming drug delivery system for controlled..:

Kranz, H. ; Bodmeier, R.
International Journal of Pharmaceutics. 332 (2007) 1-2 - p. 107-114 , 2007

Link: https://doi.org/10.1016/..

11

Effects of formulation and process variables on the release..:

KRANZ, H ; WAGNER, T
European Journal of Pharmaceutics and Biopharmaceutics. 62 (2006) 1 - p. 70-76 , 2006

Link: https://doi.org/10.1016/..

12

Development of a single unit extended release formulation f..:

Kranz, H. ; Guthmann, C. ; Wagner, T...
European Journal of Pharmaceutical Sciences. 26 (2005) 1 - p. 47-53 , 2005

Link: https://doi.org/10.1016/..

13

Development of a multi particulate extended release formula..:

Kranz, H. ; Brun, V. Le ; Wagner, T.
International Journal of Pharmaceutics. 299 (2005) 1-2 - p. 84-91 , 2005

Link: https://doi.org/10.1016/..

14

Myotoxicity studies of injectable biodegradable in-situ for..:

Kranz, H
International Journal of Pharmaceutics. 212 (2001) 1 - p. 11-18 , 2001

Link: https://doi.org/10.1016/..

15

Physicomechanical Properties of Biodegradable Poly(D,L‐lact..:

Kranz, H. ; Ubrich, N. ; Maincent, P..
Journal of Pharmaceutical Sciences. 89 (2000) 12 - p. 1558-1566 , 2000

Link: https://doi.org/10.1002/..